Report post
Novo Nordisk, a Danish pharmaceutical giant, has been recognized as one of TIME100's Most Influential Companies. Its CEO recently spoke about Catalent's role in the production of Ozempic and Wegovy, two of the company's blockbuster diabetes and weight loss drugs. Novo Nordisk has recently launched Wegovy in Britain, further expanding its global reach. Investors are advised to consider buying Novo Nordisk stock due to its strong fundamentals and promising product pipeline.

The World's Leading Crypto Trading Platform

Get my welcome gifts